Selected research
Industry Research
Computer-assisted Drug Design Platform Industry Research Report 2026
Market perspective
The global Computer-assisted Drug Design Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Computer-assisted Drug Design Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Computer-assisted Drug Design Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Computer-assisted Drug Design Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Computer-assisted Drug Design Platform include Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos and Leadscope, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Computer-assisted Drug Design Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Computer-assisted Drug Design Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Computer-assisted Drug Design Platform Market by Company
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Computer-assisted Drug Design Platform Segment by Type
Cloud-based
On-premise
Computer-assisted Drug Design Platform Segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
Computer-assisted Drug Design Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computer-assisted Drug Design Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Computer-assisted Drug Design Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computer-assisted Drug Design Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Computer-assisted Drug Design Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-premise
Applications
- Drug Discovery and Development
- Computational Physiological Medicine
- Disease Modeling
- Medical Imaging
- Predictive Analysis of Drug Targets
Companies covered
- Entelos
- Crown Bioscience
- Chemical Computing Group
- Nimbus Therapeutics
- Schrodinger
- Dassault Systemes
- Genedata
- Biognos
- Leadscope
- Rhenovia Pharma Limited
- Compugen
- Certara LP
- Prosarix
- Simulations Plus
- Strand Life Sciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Computer-assisted Drug Design Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-based
- 2.2.3 On-premise
- 2.3 Computer-assisted Drug Design Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Discovery and Development
- 2.3.3 Computational Physiological Medicine
- 2.3.4 Disease Modeling
- 2.3.5 Medical Imaging
- 2.3.6 Predictive Analysis of Drug Targets
- 2.4 Assumptions and Limitations
3 Computer-assisted Drug Design Platform Breakdown Data by Type
- 3.1 Global Computer-assisted Drug Design Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Computer-assisted Drug Design Platform Forecasted Market Size by Type (2027-2032)
4 Computer-assisted Drug Design Platform Breakdown Data by Application
- 4.1 Global Computer-assisted Drug Design Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Computer-assisted Drug Design Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Computer-assisted Drug Design Platform Market Perspective (2021-2032)
- 5.2 Global Computer-assisted Drug Design Platform Growth Trends by Region
- 5.2.1 Global Computer-assisted Drug Design Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Computer-assisted Drug Design Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Computer-assisted Drug Design Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Computer-assisted Drug Design Platform Market Dynamics
- 5.3.1 Computer-assisted Drug Design Platform Industry Trends
- 5.3.2 Computer-assisted Drug Design Platform Market Drivers
- 5.3.3 Computer-assisted Drug Design Platform Market Challenges
- 5.3.4 Computer-assisted Drug Design Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Computer-assisted Drug Design Platform Players by Revenue
- 6.1.1 Global Top Computer-assisted Drug Design Platform Players by Revenue (2021-2026)
- 6.1.2 Global Computer-assisted Drug Design Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Computer-assisted Drug Design Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Computer-assisted Drug Design Platform Head Office and Area Served
- 6.4 Global Computer-assisted Drug Design Platform Players, Product Type & Application
- 6.5 Global Computer-assisted Drug Design Platform Manufacturers Established Date
- 6.6 Global Computer-assisted Drug Design Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Computer-assisted Drug Design Platform Market Size (2021-2032)
- 7.2 North America Computer-assisted Drug Design Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
- 7.4 North America Computer-assisted Drug Design Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Computer-assisted Drug Design Platform Market Size (2021-2032)
- 8.2 Europe Computer-assisted Drug Design Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
- 8.4 Europe Computer-assisted Drug Design Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Computer-assisted Drug Design Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Computer-assisted Drug Design Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Computer-assisted Drug Design Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Computer-assisted Drug Design Platform Market Size (2021-2032)
- 10.2 South America Computer-assisted Drug Design Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
- 10.4 South America Computer-assisted Drug Design Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Computer-assisted Drug Design Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Computer-assisted Drug Design Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Entelos
- 12.1.1 Entelos Company Information
- 12.1.2 Entelos Business Overview
- 12.1.3 Entelos Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.1.4 Entelos Computer-assisted Drug Design Platform Product Portfolio
- 12.1.5 Entelos Recent Developments
- 12.2 Crown Bioscience
- 12.2.1 Crown Bioscience Company Information
- 12.2.2 Crown Bioscience Business Overview
- 12.2.3 Crown Bioscience Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.2.4 Crown Bioscience Computer-assisted Drug Design Platform Product Portfolio
- 12.2.5 Crown Bioscience Recent Developments
- 12.3 Chemical Computing Group
- 12.3.1 Chemical Computing Group Company Information
- 12.3.2 Chemical Computing Group Business Overview
- 12.3.3 Chemical Computing Group Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.3.4 Chemical Computing Group Computer-assisted Drug Design Platform Product Portfolio
- 12.3.5 Chemical Computing Group Recent Developments
- 12.4 Nimbus Therapeutics
- 12.4.1 Nimbus Therapeutics Company Information
- 12.4.2 Nimbus Therapeutics Business Overview
- 12.4.3 Nimbus Therapeutics Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.4.4 Nimbus Therapeutics Computer-assisted Drug Design Platform Product Portfolio
- 12.4.5 Nimbus Therapeutics Recent Developments
- 12.5 Schrodinger
- 12.5.1 Schrodinger Company Information
- 12.5.2 Schrodinger Business Overview
- 12.5.3 Schrodinger Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.5.4 Schrodinger Computer-assisted Drug Design Platform Product Portfolio
- 12.5.5 Schrodinger Recent Developments
- 12.6 Dassault Systemes
- 12.6.1 Dassault Systemes Company Information
- 12.6.2 Dassault Systemes Business Overview
- 12.6.3 Dassault Systemes Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.6.4 Dassault Systemes Computer-assisted Drug Design Platform Product Portfolio
- 12.6.5 Dassault Systemes Recent Developments
- 12.7 Genedata
- 12.7.1 Genedata Company Information
- 12.7.2 Genedata Business Overview
- 12.7.3 Genedata Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.7.4 Genedata Computer-assisted Drug Design Platform Product Portfolio
- 12.7.5 Genedata Recent Developments
- 12.8 Biognos
- 12.8.1 Biognos Company Information
- 12.8.2 Biognos Business Overview
- 12.8.3 Biognos Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.8.4 Biognos Computer-assisted Drug Design Platform Product Portfolio
- 12.8.5 Biognos Recent Developments
- 12.9 Leadscope
- 12.9.1 Leadscope Company Information
- 12.9.2 Leadscope Business Overview
- 12.9.3 Leadscope Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.9.4 Leadscope Computer-assisted Drug Design Platform Product Portfolio
- 12.9.5 Leadscope Recent Developments
- 12.10 Rhenovia Pharma Limited
- 12.10.1 Rhenovia Pharma Limited Company Information
- 12.10.2 Rhenovia Pharma Limited Business Overview
- 12.10.3 Rhenovia Pharma Limited Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.10.4 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Product Portfolio
- 12.10.5 Rhenovia Pharma Limited Recent Developments
- 12.11 Compugen
- 12.11.1 Compugen Company Information
- 12.11.2 Compugen Business Overview
- 12.11.3 Compugen Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.11.4 Compugen Computer-assisted Drug Design Platform Product Portfolio
- 12.11.5 Compugen Recent Developments
- 12.12 Certara LP
- 12.12.1 Certara LP Company Information
- 12.12.2 Certara LP Business Overview
- 12.12.3 Certara LP Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.12.4 Certara LP Computer-assisted Drug Design Platform Product Portfolio
- 12.12.5 Certara LP Recent Developments
- 12.13 Prosarix
- 12.13.1 Prosarix Company Information
- 12.13.2 Prosarix Business Overview
- 12.13.3 Prosarix Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.13.4 Prosarix Computer-assisted Drug Design Platform Product Portfolio
- 12.13.5 Prosarix Recent Developments
- 12.14 Simulations Plus
- 12.14.1 Simulations Plus Company Information
- 12.14.2 Simulations Plus Business Overview
- 12.14.3 Simulations Plus Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.14.4 Simulations Plus Computer-assisted Drug Design Platform Product Portfolio
- 12.14.5 Simulations Plus Recent Developments
- 12.15 Strand Life Sciences
- 12.15.1 Strand Life Sciences Company Information
- 12.15.2 Strand Life Sciences Business Overview
- 12.15.3 Strand Life Sciences Revenue in Computer-assisted Drug Design Platform Business (2021-2026)
- 12.15.4 Strand Life Sciences Computer-assisted Drug Design Platform Product Portfolio
- 12.15.5 Strand Life Sciences Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst